|

Singapore: Growth outlook unchanged despite tighter COVID measures – UOB

Economist at UOB Group Barnabas Gan reviews the latest COVID-19 measures implemented in Singapore and the impact on the growth prospects.

Key Quotes

“Singapore’s multi-ministry task force will further tighten social restriction measures effective 16 May 2021. The new measures, coined as Phase Two (Heightened Alert) will be in place until 13 June 2021.”

“First-order negative impacts will likely be on Singapore’s retail sector, especially the food & beverage industry.”

“We note that Singapore’s economy has shown signs of recovery in the first quarter of 2021. Based on the advance estimates by the Ministry of Trade and Industry (MTI), Singapore’s 1Q21 GDP expanded +0.2% y/y (+2.0% q/q sa), although we think that it may be upgraded to +0.9% y/y (+2.7% q/q sa) given the stronger-than-expected manufacturing growth in 1Q21.”

“Despite Singapore’s retail sector possibly seeing further negative effects due to the tightened measures, we note that other key growth pillars such as manufacturing (21.9% of GDP in 2020) and other major services clusters such as finance & insurance (14.3% of GDP), business services (13.0% of GDP), and information & communications (4.8% of GDP) may see little impact from the tightened measures.”

“While we projected little impact on Singapore’s GDP in 2021 from the initial announcement of Phase Two (effective 8 May), the further tightening of social distancing measures announced today will likely add some downside impact on Singapore’s retail sector, which in turn could inject marginal downside risk to our full-year GDP outlook of 5.5% in 2021, albeit transitory if the tightened measures last till 13 Jun and are subsequently relaxed. For now, we would prefer to hold our growth forecast at the 5.5%, until further clarity on how the COVID-19 situation evolves in the foreseeable future.”

Author

Pablo Piovano

Born and bred in Argentina, Pablo has been carrying on with his passion for FX markets and trading since his first college years.

More from Pablo Piovano
Share:

Editor's Picks

EUR/USD struggles to hold above 1.1800 ahead of US data

EUR/USD finds it difficult to gather recovery momentum and retreats below 1.1800 in the second half of the day on Thursday. The US Dollar (USD) stays resilient against its peers after the hawkish surprise in FOMC Minutes, weighing on the pair ahead of the next batch of US data.

GBP/USD recovers above 1.3500 amid better mood

GBP/USD finds fresh demand and rises back above 1.3500 in the European session on Thursday. Improving risk sentiment and renewed US Dollar weakness are helping the pair recover ground ahead of mid-tier US data releases and Fedspeak. 

Gold retreats from daily highs, trades below $5,000

Gold finds it difficult to stabilize above the $5,000 psychological mark on Thursday and trades slightly below this level in the early American session. Escalating geopolitical tensions in the Middle East help XAU/USD hold its ground, while the broad-based USD strength caps the pair's upside.

Injective token surges over 13% following the approval of the mainnet upgrade proposal

Injective price rallies over 13% on Thursday after the network confirmed the approval of its IIP-619 proposal. The green light for the mainnet upgrade has boosted traders’ sentiment, as the upgrade aims to scale Injective’s real-time Ethereum Virtual Machine architecture and enhance its capabilities to support next-generation payments. The technical outlook suggests further gains if INJ breaks above key resistance.

Hawkish Fed minutes and a market finding its footing

It was green across the board for US Stock market indexes at the close on Wednesday, with most S&P 500 names ending higher, adding 38 points (0.6%) to 6,881 overall. At the GICS sector level, energy led gains, followed by technology and consumer discretionary, while utilities and real estate posted the largest losses.

Injective token surges over 13% following the approval of the mainnet upgrade proposal

Injective price rallies over 13% on Thursday after the network confirmed the approval of its IIP-619 proposal. The green light for the mainnet upgrade has boosted traders’ sentiment, as the upgrade aims to scale Injective’s real-time Ethereum Virtual Machine architecture and enhance its capabilities to support next-generation payments.